Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
Karino, Y., Ozeki, I., Hige, S., Kimura, M., Arakawa, T., Nakajima, T., Kuwata, Y., Sato, T., Ohmura, T., Toyota, J.
Published in Journal of viral hepatitis (01.05.2014)
Published in Journal of viral hepatitis (01.05.2014)
Get full text
Journal Article
P0997 : WFA+-M2BP is a predictive factor for fibrosis progression in NAFLD
Nakajima, T, Ozeki, I, Hige, S, Karino, Y, Toyota, J
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
The Real World Experience of Daclatasvir and Asunaprevir Combination Therapy for More Elderly Patients thanthe Clinical Trial Subjects with Genotype 1b Chronic Hepatitis C
Hige, S, Karino, Y, Ozeki, I, Yamaguchi, M, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Preparation of single-helix carbon microcoils by catalytic CVD process
Yang, Shaoming, Ozeki, I., Chen, Xiuqin, Katsuno, T., Motojima, S.
Published in Thin solid films (01.01.2008)
Published in Thin solid films (01.01.2008)
Get full text
Journal Article
Conference Proceeding
825 ANALYSIS OF THE OPTIMAL TVR DOSE PER WEIGHT JUDGING FROM ANEMIA DURING PEG-IFN/RBV/TVR COMBINATION THERAPY
Karino, Y, Ozeki, I, Hige, S, Toyota, J, Imamura, M, Tsuge, M, Chayama, K, Akuta, N, Suzuki, F, Kumada, H
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b
Toyota, J., Ozeki, I., Karino, Y., Asahina, Y., Izumi, N., Takahashi, S., Kawakami, Y., Chayama, K., Kamiya, N., Aoki, K., Yamada, I., Suzuki, Y., Suzuki, F., Kumada, H.
Published in Journal of viral hepatitis (01.03.2013)
Published in Journal of viral hepatitis (01.03.2013)
Get full text
Journal Article
1124 2250MG/DAY OF TELAPREVIR DOSAGE IMPAIR THE RIBAVIRIN DOSAGE AND CLINICAL EFFECT OF TRIPLE THERAPY IN THE PATIENTS WITH A LOW TOTAL CLEARANCE OF RIBAVIRIN
Karino, Y, Nakajima, T, Ozeki, I, Toyota, J, Imamura, M, Tsuge, M, Chayama, K, Akuta, N, Suzuki, F, Kumada, H
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
835 RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TVR COMBINATION THERAPY IS A GOOD PREDICTIVE MARKER OF RENAL DYSFUNCTION AND ANEMIA
Karino, Y, Ozeki, I, Hige, S, Miyakawa, M, Kimura, M, Arakawa, T, Nakajima, T, Kuwata, Y, Sato, T, Ohmura, T, Toyota, J
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus
Kaneto, H, Sasaki, S, Yamamoto, H, Itoh, F, Toyota, M, Suzuki, H, Ozeki, I, Iwata, N, Ohmura, T, Satoh, T, Karino, Y, Toyota, J, Satoh, M, Endo, T, Omata, M, Imai, K
Published in Gut (01.03.2001)
Published in Gut (01.03.2001)
Get full text
Journal Article
1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY
Karino, Y, Ozeki, I, Toyota, J, Imamura, M, Tsuge, M, Chayama, K, Sezaki, H, Akuta, N, Kumada, H
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
268 RELATIONSHIP OF SERUM IP-10 LEVELS WHICH REFLECTS HEPATIC INTERFERON STIMULATING GENE INDUCTION AND ANTIVIRAL EFFECT OF PEG/RBV COMBINATION THERAPY IN PATIENT WITH CHRONIC HEPATITIS C
Karino, Y, Toyota, J, Arakawa, T, Kuwata, Y, Akaike, J, Ozeki, I, Sato, T, Ohmura, T
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
P1216 EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY IN PATIENTS WITH HCV GENOTYPE 1 – COMPARISON WITH TELAPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY AND PEG-INTERFERON/RIBAVIRIN THERAPY
Nakajima, T, Kimura, M, Arakawa, T, Kuwata, Y, Ozeki, I, Sato, T, Ohmura, T, Hige, S, Karino, Y, Toyota, J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
799 TIMING OF HCV NEGATIVITY AND POSSIBLE SVR MAY BE PREDICTABLE BY HCVRNA LEVELS MEASURED WITH TAQMAN HCV IN EARLY TREATMENT PHASE
Karino, Y, Toyota, J, Arakawa, T, Kuwata, Y, Akaike, J, Ozeki, I, Yamazaki, K, Sato, T, Ohmura, T
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article
FRI-384 - Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C
Ozeki, I., Suii, H., Tatsumi, R., Yamaguchi, M., Kimura, M., Arakawa, T., Kuwata, Y., Ohmura, T., Hige, S., Karino, Y., Toyota, J.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C
Ozeki, I., Suii, H., Tatsumi, R., Yamaguchi, M., Kimura, M., Arakawa, T., Kuwata, Y., Ohmura, T., Hige, S., Karino, Y., Toyota, J.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Determination of the optimum timing of the start of nucleoside analogue by FIB-4 index for hepatitis B patients from the viewpoint of suppressing hepatocarcinogenesis
Hige, S., Ozeki, I., Tatsumi, R., Yamaguchi, M., Kimura, M., Arakawa, T., Nakajima, T., Kuwata, Y., Ohmura, T., Toyota, J., Karino, Y.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
FRI-330 - Determination of the optimum timing of the start of nucleoside analogue by FIB-4 index for hepatitis B patients from the viewpoint of suppressing hepatocarcinogenesis
Hige, S., Ozeki, I., Tatsumi, R., Yamaguchi, M., Kimura, M., Arakawa, T., Nakajima, T., Kuwata, Y., Ohmura, T., Toyota, J., Karino, Y.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article